NL-OMON56348尚未招募不适用
Genetic screening in Parkinson*s disease patients to identify GBA1 mutation carriers for future clinical trials. - Genetic screening for GBA1
Vanqua Bio Inc.0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Age 40-80 years of age at screening (inclusive).
- •2. All participants must understand and provide written informed consent prior
- •to any study-specific procedures
- •3. Able to speak, read, and understand study procedures in Dutch sufficiently
- •to allow completion of all study assessments.
- •4. Patient-reported clinical diagnosis of Parkinson*s disease by a neurologist
- •within the last 10 years.
排除标准
- •1. Known non-GBA-1 mutation for Parkinson*s disease
研究者
相似试验
进行中（未招募）
Unknown
Genetic screening for GBA1 in Parkinson’s disease patientsParkinson's disease, ParkinsonismNervous System DiseasesISRCTN99451262Vanqua Bio Inc.1,000
已完成
不适用
Genetic screening in Parkinson*s Disease in order to identify patients who can participate in clinical trials with new targeted therapiesParkinson's diseasemovement disorder10028037NL-OMON45734Centre for Human Drug Research1,000
招募中
不适用
Study to investigate mutations in the GBA1 and LRRK2 genes in Parkinson’s Disease patients.Parkinson’s DiseaseNL-OMON23101CHDR1,000
尚未招募
不适用
Search for Genetic Factors in Parkinson's Disease - IIParkinsonismParkinson's DiseaseNL-OMON51549Erasmus MC, Universitair Medisch Centrum Rotterdam700
已完成
不适用
Search for Genetic Factors in Parkinson*s diseaseParkinsonism1002929910028037Parkinson's DiseaseNL-OMON37785Erasmus MC, Universitair Medisch Centrum Rotterdam700